FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

24685011000001105: Doxylamine 10mg / Pyridoxine 10mg modified-release tablets 300 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 23-Jul 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
80154201000001119 Doxylamine 10mg / Pyridoxine 10mg modified-release tablets 300 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
80154301000001111 Doxylamine 10mg / Pyridoxine 10mg modified-release tablets 300 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Doxylamine 10mg / Pyridoxine 10mg modified-release tablets 300 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Doxylamine 10mg / Pyridoxine 10mg modified-release tablets 300 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Doxylamine 10mg / Pyridoxine 10mg modified-release tablets 300 tablet Has VMP Doxylamine 10mg / Pyridoxine 10mg modified-release tablets true Inferred relationship Existential restriction modifier
Doxylamine 10mg / Pyridoxine 10mg modified-release tablets 300 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Doxylamine 10mg / Pyridoxine 10mg modified-release tablets 300 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Doxylamine 10mg / Pyridoxine 10mg modified-release tablets 300 tablet Has specific active ingredient Doxylamine succinate true Inferred relationship Existential restriction modifier
Doxylamine 10mg / Pyridoxine 10mg modified-release tablets 300 tablet Has specific active ingredient Pyridoxine hydrochloride true Inferred relationship Existential restriction modifier
Doxylamine 10mg / Pyridoxine 10mg modified-release tablets 300 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Diclectin modified-release tablets (Imported (Canada)) 300 tablet Is a True Doxylamine 10mg / Pyridoxine 10mg modified-release tablets 300 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start